Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

Q Zhang1, S Choo, J Everard

  • 1Sheffield Institute for Vaccine Studies, Division of Child Health, Children's Hospital, University of Sheffield, Sheffield, United Kingdom. q.zhang@sheffield.ac.uk

Infection and Immunity
|April 18, 2000
PubMed

Insights

Meningococcal conjugate vaccines induce significant salivary immunoglobulin A and G antibodies in school children. The conjugate vaccine elicited a stronger salivary IgG response than the polysaccharide vaccine, suggesting potential for enhanced mucosal immunity.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Haemophilus influenzae type b (Hib) conjugate vaccines reduce nasopharyngeal carriage and provide herd immunity, likely via mucosal antibodies.
  • This study investigates mucosal antibody responses to meningococcal vaccines, exploring if similar effects apply to other invasive bacterial infections spread by nasopharyngeal carriage.

Purpose of the Study:

  • To investigate mucosal antibody responses (salivary IgA and IgG) to meningococcal C conjugate and A/C polysaccharide vaccines in school children.
  • To compare the efficacy of conjugate versus polysaccharide vaccines in eliciting mucosal antibody responses.

Main Methods:

  • 106 school children (11-17 years) were randomized to receive either a meningococcal C conjugate or A/C polysaccharide vaccine.
  • Unstimulated saliva samples were collected pre-immunization and at 1, 6, and 12 months post-immunization.
  • Saliva and serum samples were assayed for specific IgA, IgG, and secretory component using ELISA.

Main Results:

  • Both vaccines induced significant increases in salivary IgA and IgG antibody titers one month post-immunization, with subsequent decreases by 6 months.
  • Salivary IgA responses correlated with secretory component, suggesting local production, while salivary IgG correlated with serum IgG, suggesting serum derivation.
  • The conjugate vaccine induced significantly higher salivary IgG responses compared to the polysaccharide vaccine, but IgA responses were similar between vaccine types.

Conclusions:

  • Meningococcal conjugate and polysaccharide vaccines stimulate significant salivary IgA and IgG antibody responses in adolescents.
  • The conjugate vaccine demonstrates a superior ability to induce salivary IgG compared to the polysaccharide vaccine.
  • Further research is required to determine the functional significance of these observed mucosal immune responses.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...